Early-stage funding slumps toward post-pandemic low, piling more pressure on biotech startups Read more →

FDA advisory committee set to weigh taking action on certain unapproved peptides Read more →

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen Read more →